Literature DB >> 16690671

Diagnosis and management of dysmenorrhoea.

Michelle Proctor1, Cynthia Farquhar.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16690671      PMCID： PMC1459624          DOI： 10.1136/bmj.332.7550.1134

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  24 in total

Review 1.  Combined oral contraceptive pill (OCP) as treatment for primary dysmenorrhoea.

Authors:  M L Proctor; H Roberts; C M Farquhar
Journal:  Cochrane Database Syst Rev       Date:  2001

2.  A placebo-controlled double-blind crossover investigation of the side effects attributed to oral contraceptives.

Authors:  J W Goldzieher; L E Moses; E Averkin; C Scheel; B Z Taber
Journal:  Fertil Steril       Date:  1971-09       Impact factor: 7.329

3.  Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis.

Authors:  P Vercellini; O De Giorgi; S Oldani; I Cortesi; S Panazza; P G Crosignani
Journal:  Am J Obstet Gynecol       Date:  1996-08       Impact factor: 8.661

Review 4.  Transcutaneous electrical nerve stimulation and acupuncture for primary dysmenorrhoea.

Authors:  M L Proctor; C A Smith; C M Farquhar; R W Stones
Journal:  Cochrane Database Syst Rev       Date:  2002

5.  Continuous, low-level, topical heat wrap therapy as compared to acetaminophen for primary dysmenorrhea.

Authors:  Mark Akin; William Price; Gonzalo Rodriguez; Geetha Erasala; George Hurley; Roger P Smith
Journal:  J Reprod Med       Date:  2004-09       Impact factor: 0.142

6.  Trial of the calcium antagonist nifedipine in the treatment of primary dysmenorrhoea.

Authors:  B Sandahl; U Ulmsten; K E Andersson
Journal:  Arch Gynecol       Date:  1979-08

7.  The natural history of primary dysmenorrhoea: a longitudinal study.

Authors:  Alicia M Weissman; Arthur J Hartz; Michael D Hansen; Susan R Johnson
Journal:  BJOG       Date:  2004-04       Impact factor: 6.531

Review 8.  Nonsteroidal anti-inflammatory drugs for primary dysmenorrhoea.

Authors:  J Marjoribanks; M L Proctor; C Farquhar
Journal:  Cochrane Database Syst Rev       Date:  2003

9.  A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis.

Authors:  P Vercellini; L Trespidi; A Colombo; N Vendola; M Marchini; P G Crosignani
Journal:  Fertil Steril       Date:  1993-07       Impact factor: 7.329

10.  Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study.

Authors:  Paolo Vercellini; Giada Frontino; Olga De Giorgi; Giorgio Aimi; Barbara Zaina; Pier Giorgio Crosignani
Journal:  Fertil Steril       Date:  2003-08       Impact factor: 7.329
View more
  82 in total

1.  Psychometric validation of the dysmenorrhea daily diary (DysDD): a patient-reported outcome for dysmenorrhea.

Authors:  Allison M Nguyen; Rob Arbuckle; Tjeerd Korver; Fang Chen; Beverley Taylor; Alice Turnbull; Josephine M Norquist
Journal:  Qual Life Res       Date:  2017-04-12       Impact factor: 4.147

2.  A qualitative study to develop a patient-reported outcome for dysmenorrhea.

Authors:  Allison Martin Nguyen; Louise Humphrey; Helen Kitchen; Tayyaba Rehman; Josephine M Norquist
Journal:  Qual Life Res       Date:  2014-07-22       Impact factor: 4.147

3.  Safety data and beneficial effects of the combined oral contraceptive ethinylestradiol 0.03 mg/chlormadinone acetate 2 mg (Belara®): a 13-cycle, observational study in routine clinical practice.

Authors:  Daphnee S Pushparajah; Petra Röhm; Kornelia Höschen; Dagmar Albers; Christina Nowack
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

4.  Efficacy of phloroglucinol for the treatment of pain of gynaecologic or obstetrical origin: a systematic review of literature of randomised controlled trials.

Authors:  Blanchard Clara; Vanderkam Paul; Pouchain Denis; Mignot Stéphanie; Vaillant-Roussel Hélène; Boussageon Rémy
Journal:  Eur J Clin Pharmacol       Date:  2019-08-21       Impact factor: 2.953

Review 5.  Dysmenorrhea in adolescents: diagnosis and treatment.

Authors:  Linda French
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

6.  CYP1A1 gene polymorphisms in modifying the association between passive smoking and primary dysmenorrhea.

Authors:  Na Li; Hong Liu; Changzhong Chen; Fan Yang; Zhiping Li; Zhian Fang; Lihua Wang; Yonghua Hu; Dafang Chen
Journal:  Ann Epidemiol       Date:  2007-08-28       Impact factor: 3.797

7.  Stressful Parental-Bonding Exaggerates the Functional and Emotional Disturbances of Primary Dysmenorrhea.

Authors:  Kai Xu; Liuxi Chen; Lingyun Fu; Shaofang Xu; Hongying Fan; Qianqian Gao; You Xu; Wei Wang
Journal:  Int J Behav Med       Date:  2016-08

8.  Primary dysmenorrhea: prevalence in adolescent population of Tbilisi, Georgia and risk factors.

Authors:  Tinatin Gagua; Besarion Tkeshelashvili; David Gagua
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-09-01

9.  Prevalence of endometriosis among adolescent school girls with severe dysmenorrhea: A cross sectional prospective study.

Authors:  Ahmed Ragab; Maher Shams; Ahmed Badawy; Mohamed Alkhatim Alsammani
Journal:  Int J Health Sci (Qassim)       Date:  2015-07

10.  Rates of Anovulation in Adolescents and Young Adults with Moderate to Severe Primary Dysmenorrhea and Those without Primary Dysmenorrhea.

Authors:  Laura C Seidman; Kathleen M Brennan; Andrea J Rapkin; Laura A Payne
Journal:  J Pediatr Adolesc Gynecol       Date:  2017-10-07       Impact factor: 1.814
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.